Allscripts Healthcare Solutions Inc MDRX

NAS: MDRX | ISIN: US01988P1084   17/09/2025
4,750 USD (0,00%)
(0,00%)   17/09/2025

28 februari 2024 · Sprinklr Set to Join S&P SmallCap 600 · Persbericht

6 februari 2024 · Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation · Persbericht

19 januari 2024 · Deadline in 3 Days for Veradigm Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. (MDRX) Investors of Filing Deadline in Class Action Lawsuit · Persbericht

18 januari 2024 · VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options · Persbericht

11 januari 2024 · VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options · Persbericht

11 januari 2024 · MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit · Persbericht

10 januari 2024 · MDRX Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Veradigm Inc. (MDRX) · Persbericht

9 januari 2024 · Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner · Persbericht

4 januari 2024 · VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options · Persbericht

2 januari 2024 · Kessler Topaz Meltzer & Check, LLP Notifies Veradigm Inc. Investors of Securities Fraud Class Action Lawsuit Filed on Their Behalf · Persbericht

28 december 2023 · MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit · Persbericht

28 december 2023 · VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options · Persbericht

25 december 2023 · Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm · Persbericht

21 december 2023 · VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options · Persbericht

13 december 2023 · MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit · Persbericht

5 december 2023 · VERADIGM SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options · Persbericht

13 oktober 2023 · MDRX INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into Veradigm Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm · Persbericht

6 oktober 2023 · Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency · Persbericht

29 september 2023 · Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Veradigm Inc. (MDRX) on Behalf of Investors · Persbericht

28 september 2023 · INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Veradigm Inc. (MDRX) on Behalf of Investors · Persbericht

Mijn selecties